New government-funded guidelines promote a more positive approach to initiating biosimilars and switching to them in hospital settings. The new 2021 guiding principles have been released as part of the Department of Health’s ‘Value in Prescribing’ initiative to promote uptake of biosimilars, updating previous guidance released in 2016. Currently there are PBS listed biosimilars for ...
Hospitals given new advice to promote biosimilars
By Michael Woodhead
8 Dec 2021